Global Candesartan Cilexetil Drug Market Insights, Forecast to 2025

Publisher Name :
Date: 17-Jun-2019
No. of pages: 118
Inquire Before Buying

Candesartan cilexetil (candesartan) is a drug used for treating high blood pressure (hypertension). It is in a class of drugs called angiotensin receptor blockers (ARBs) which includes losartan (Cozaar), valsartan (Diovan), and irbesartan (Avapro). Angiotensin, formed in the blood by the action of angiotensin converting enzyme (ACE), is a powerful chemical that attaches to angiotensin receptors found in many tissues but primarily on smooth muscle cells surrounding blood vessels. Angiotensin's attachment to the receptors causes the muscle cells to contract and the blood vessels to narrow (vasoconstrict) which leads to an increase in blood pressure. Candesartan blocks the angiotensin receptor and therby prevents the action of angiotensin. As a result blood vessels expand and blood pressure is reduced. Candesartan was approved by the FDA in 1998.

The global Candesartan Cilexetil Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Candesartan Cilexetil Drug market based on company, product type, end user and key regions.

This report studies the global market size of Candesartan Cilexetil Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Candesartan Cilexetil Drug in these regions.

This research report categorizes the global Candesartan Cilexetil Drug market by top players/brands, region, type and end user. This report also studies the global Candesartan Cilexetil Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- AstraZeneca

- ANI Pharmaceuticals

- Mylan

- Zydus Pharmaceuticals

- MACLEODS

- Alembic Pharmaceuticals

- Teva

- LUPIN

- Sun Pharmaceutical

- Chongqing Shenghuaxi Pharma

Market size by Product

- 4 mg Tablets

- 8 mg Tablets

- 16 mg Tablets

- 32 mg Tablets

Market size by End User

- Essential hypertension in adults

- Hypertension in children and adolescents aged 6 to < 18 years

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Candesartan Cilexetil Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Candesartan Cilexetil Drug market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Candesartan Cilexetil Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Candesartan Cilexetil Drug submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Candesartan Cilexetil Drug are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Candesartan Cilexetil Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Candesartan Cilexetil Drug Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Candesartan Cilexetil Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Candesartan Cilexetil Drug Market Size Growth Rate by Product
1.4.2 4 mg Tablets
1.4.3 8 mg Tablets
1.4.4 16 mg Tablets
1.4.5 32 mg Tablets
1.5 Market by End User
1.5.1 Global Candesartan Cilexetil Drug Market Size Growth Rate by End User
1.5.2 Essential hypertension in adults
1.5.3 Hypertension in children and adolescents aged 6 to < 18 years
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Candesartan Cilexetil Drug Market Size
2.1.1 Global Candesartan Cilexetil Drug Revenue 2014-2025
2.1.2 Global Candesartan Cilexetil Drug Sales 2014-2025
2.2 Candesartan Cilexetil Drug Growth Rate by Regions
2.2.1 Global Candesartan Cilexetil Drug Sales by Regions
2.2.2 Global Candesartan Cilexetil Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Candesartan Cilexetil Drug Sales by Manufacturers
3.1.1 Candesartan Cilexetil Drug Sales by Manufacturers
3.1.2 Candesartan Cilexetil Drug Sales Market Share by Manufacturers
3.1.3 Global Candesartan Cilexetil Drug Market Concentration Ratio (CR5 and HHI)
3.2 Candesartan Cilexetil Drug Revenue by Manufacturers
3.2.1 Candesartan Cilexetil Drug Revenue by Manufacturers (2014-2019)
3.2.2 Candesartan Cilexetil Drug Revenue Share by Manufacturers (2014-2019)
3.3 Candesartan Cilexetil Drug Price by Manufacturers
3.4 Candesartan Cilexetil Drug Manufacturing Base Distribution, Product Types
3.4.1 Candesartan Cilexetil Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Candesartan Cilexetil Drug Product Type
3.4.3 Date of International Manufacturers Enter into Candesartan Cilexetil Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Candesartan Cilexetil Drug Sales by Product
4.2 Global Candesartan Cilexetil Drug Revenue by Product
4.3 Candesartan Cilexetil Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Candesartan Cilexetil Drug Breakdown Data by End User
6 North America
6.1 North America Candesartan Cilexetil Drug by Countries
6.1.1 North America Candesartan Cilexetil Drug Sales by Countries
6.1.2 North America Candesartan Cilexetil Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Candesartan Cilexetil Drug by Product
6.3 North America Candesartan Cilexetil Drug by End User
7 Europe
7.1 Europe Candesartan Cilexetil Drug by Countries
7.1.1 Europe Candesartan Cilexetil Drug Sales by Countries
7.1.2 Europe Candesartan Cilexetil Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Candesartan Cilexetil Drug by Product
7.3 Europe Candesartan Cilexetil Drug by End User
8 Asia Pacific
8.1 Asia Pacific Candesartan Cilexetil Drug by Countries
8.1.1 Asia Pacific Candesartan Cilexetil Drug Sales by Countries
8.1.2 Asia Pacific Candesartan Cilexetil Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Candesartan Cilexetil Drug by Product
8.3 Asia Pacific Candesartan Cilexetil Drug by End User
9 Central & South America
9.1 Central & South America Candesartan Cilexetil Drug by Countries
9.1.1 Central & South America Candesartan Cilexetil Drug Sales by Countries
9.1.2 Central & South America Candesartan Cilexetil Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Candesartan Cilexetil Drug by Product
9.3 Central & South America Candesartan Cilexetil Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Candesartan Cilexetil Drug by Countries
10.1.1 Middle East and Africa Candesartan Cilexetil Drug Sales by Countries
10.1.2 Middle East and Africa Candesartan Cilexetil Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Candesartan Cilexetil Drug by Product
10.3 Middle East and Africa Candesartan Cilexetil Drug by End User
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Candesartan Cilexetil Drug Products Offered
11.1.5 AstraZeneca Recent Development
11.2 ANI Pharmaceuticals
11.2.1 ANI Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 ANI Pharmaceuticals Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 ANI Pharmaceuticals Candesartan Cilexetil Drug Products Offered
11.2.5 ANI Pharmaceuticals Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Company Business Overview
11.3.3 Mylan Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Mylan Candesartan Cilexetil Drug Products Offered
11.3.5 Mylan Recent Development
11.4 Zydus Pharmaceuticals
11.4.1 Zydus Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Zydus Pharmaceuticals Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Zydus Pharmaceuticals Candesartan Cilexetil Drug Products Offered
11.4.5 Zydus Pharmaceuticals Recent Development
11.5 MACLEODS
11.5.1 MACLEODS Company Details
11.5.2 Company Business Overview
11.5.3 MACLEODS Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 MACLEODS Candesartan Cilexetil Drug Products Offered
11.5.5 MACLEODS Recent Development
11.6 Alembic Pharmaceuticals
11.6.1 Alembic Pharmaceuticals Company Details
11.6.2 Company Business Overview
11.6.3 Alembic Pharmaceuticals Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Alembic Pharmaceuticals Candesartan Cilexetil Drug Products Offered
11.6.5 Alembic Pharmaceuticals Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Company Business Overview
11.7.3 Teva Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Teva Candesartan Cilexetil Drug Products Offered
11.7.5 Teva Recent Development
11.8 LUPIN
11.8.1 LUPIN Company Details
11.8.2 Company Business Overview
11.8.3 LUPIN Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 LUPIN Candesartan Cilexetil Drug Products Offered
11.8.5 LUPIN Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Details
11.9.2 Company Business Overview
11.9.3 Sun Pharmaceutical Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sun Pharmaceutical Candesartan Cilexetil Drug Products Offered
11.9.5 Sun Pharmaceutical Recent Development
11.10 Chongqing Shenghuaxi Pharma
11.10.1 Chongqing Shenghuaxi Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Chongqing Shenghuaxi Pharma Candesartan Cilexetil Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Chongqing Shenghuaxi Pharma Candesartan Cilexetil Drug Products Offered
11.10.5 Chongqing Shenghuaxi Pharma Recent Development
12 Future Forecast
12.1 Candesartan Cilexetil Drug Market Forecast by Regions
12.1.1 Global Candesartan Cilexetil Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Candesartan Cilexetil Drug Revenue Forecast by Regions 2019-2025
12.2 Candesartan Cilexetil Drug Market Forecast by Product
12.2.1 Global Candesartan Cilexetil Drug Sales Forecast by Product 2019-2025
12.2.2 Global Candesartan Cilexetil Drug Revenue Forecast by Product 2019-2025
12.3 Candesartan Cilexetil Drug Market Forecast by End User
12.4 North America Candesartan Cilexetil Drug Forecast
12.5 Europe Candesartan Cilexetil Drug Forecast
12.6 Asia Pacific Candesartan Cilexetil Drug Forecast
12.7 Central & South America Candesartan Cilexetil Drug Forecast
12.8 Middle East and Africa Candesartan Cilexetil Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Candesartan Cilexetil Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Candesartan Cilexetil Drug Product Picture
Table Candesartan Cilexetil Drug Market Segments
Table Key Manufacturers Candesartan Cilexetil Drug Covered
Table Global Candesartan Cilexetil Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Candesartan Cilexetil Drug Sales Market Share by Product 2014-2025
Figure 4 mg Tablets Product Picture
Table Major Manufacturers of 4 mg Tablets
Figure 8 mg Tablets Product Picture
Table Major Manufacturers of 8 mg Tablets
Figure 16 mg Tablets Product Picture
Table Major Manufacturers of 16 mg Tablets
Figure 32 mg Tablets Product Picture
Table Major Manufacturers of 32 mg Tablets
Table Global Candesartan Cilexetil Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Essential hypertension in adults
Figure Hypertension in children and adolescents aged 6 to < 18 years
Figure Others
Figure Candesartan Cilexetil Drug Report Years Considered
Figure Global Candesartan Cilexetil Drug Market Size 2014-2025 (Million US$)
Figure Global Candesartan Cilexetil Drug Sales 2014-2025 (K Units)
Table Global Candesartan Cilexetil Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Candesartan Cilexetil Drug Sales by Regions 2014-2019 (K Units)
Table Global Candesartan Cilexetil Drug Sales Market Share by Regions 2014-2019
Figure Global Candesartan Cilexetil Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Candesartan Cilexetil Drug Sales Market Share by Regions
Table Global Candesartan Cilexetil Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Candesartan Cilexetil Drug Revenue Market Share by Regions 2014-2019
Figure Global Candesartan Cilexetil Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Candesartan Cilexetil Drug Revenue Market Share by Regions
Table Global Candesartan Cilexetil Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Candesartan Cilexetil Drug Sales Share by Manufacturers (2014-2019)
Figure Global Candesartan Cilexetil Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Candesartan Cilexetil Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Candesartan Cilexetil Drug Revenue Share by Manufacturers (2014-2019)
Figure Candesartan Cilexetil Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Candesartan Cilexetil Drug Price (2014-2019) (USD/Unit)
Table Candesartan Cilexetil Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Candesartan Cilexetil Drug Product Type
Table Date of International Manufacturers Enter into Candesartan Cilexetil Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Candesartan Cilexetil Drug Sales by Product (2014-2019) (K Units)
Table Global Candesartan Cilexetil Drug Sales Share by Product (2014-2019)
Figure Global Candesartan Cilexetil Drug Sales Market Share by Product (2014-2019)
Figure Global Candesartan Cilexetil Drug Sales Market Share by Product in 2018
Table Global Candesartan Cilexetil Drug Revenue by Product (2014-2019) (Million US$)
Table Global Candesartan Cilexetil Drug Revenue Share by Product (2014-2019)
Figure Global Candesartan Cilexetil Drug Revenue Market Share by Product (2014-2019)
Figure Global Candesartan Cilexetil Drug Revenue Market Share by Product in 2018
Table Candesartan Cilexetil Drug Price by Product 2014-2019 (USD/Unit)
Table Global Candesartan Cilexetil Drug Sales by End User (2014-2019) (K Units)
Table Global Candesartan Cilexetil Drug Sales Share by End User (2014-2019)
Figure Global Sales Candesartan Cilexetil Drug Market Share by End User (2014-2019)
Figure Global Sales Candesartan Cilexetil Drug Market Share by End User in 2018
Figure North America Candesartan Cilexetil Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America Candesartan Cilexetil Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Candesartan Cilexetil Drug Sales by Countries (2014-2019) (K Units)
Table North America Candesartan Cilexetil Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Candesartan Cilexetil Drug Sales Market Share by Countries
Table North America Candesartan Cilexetil Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Candesartan Cilexetil Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Candesartan Cilexetil Drug Revenue Market Share by Countries
Figure United States Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Candesartan Cilexetil Drug Sales by Product (2014-2019) (K Units)
Table North America Candesartan Cilexetil Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Candesartan Cilexetil Drug Market Share by Product
Table North America Candesartan Cilexetil Drug Sales by End User (2014-2019) (K Units)
Table North America Candesartan Cilexetil Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Candesartan Cilexetil Drug Market Share by End User
Figure Europe Candesartan Cilexetil Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe Candesartan Cilexetil Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Candesartan Cilexetil Drug Sales by Countries (2014-2019) (K Units)
Table Europe Candesartan Cilexetil Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Candesartan Cilexetil Drug Sales Market Share by Countries
Table Europe Candesartan Cilexetil Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Candesartan Cilexetil Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Candesartan Cilexetil Drug Revenue Market Share by Countries
Figure Germany Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure France Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Candesartan Cilexetil Drug Sales by Product (2014-2019) (K Units)
Table Europe Candesartan Cilexetil Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Candesartan Cilexetil Drug Market Share by Product
Table Europe Candesartan Cilexetil Drug Sales by End User (2014-2019) (K Units)
Table Europe Candesartan Cilexetil Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Candesartan Cilexetil Drug Market Share by End User
Figure Asia Pacific Candesartan Cilexetil Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Candesartan Cilexetil Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Candesartan Cilexetil Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Candesartan Cilexetil Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Candesartan Cilexetil Drug Sales Market Share by Countries
Table Asia Pacific Candesartan Cilexetil Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Candesartan Cilexetil Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Candesartan Cilexetil Drug Revenue Market Share by Countries
Figure China Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure China Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Candesartan Cilexetil Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific Candesartan Cilexetil Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Candesartan Cilexetil Drug Market Share by Product
Table Asia Pacific Candesartan Cilexetil Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific Candesartan Cilexetil Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Candesartan Cilexetil Drug Market Share by End User
Figure Central & South America Candesartan Cilexetil Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Candesartan Cilexetil Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Candesartan Cilexetil Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America Candesartan Cilexetil Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Candesartan Cilexetil Drug Sales Market Share by Countries
Table Central & South America Candesartan Cilexetil Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Candesartan Cilexetil Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Candesartan Cilexetil Drug Revenue Market Share by Countries
Figure Brazil Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Candesartan Cilexetil Drug Sales by Product (2014-2019) (K Units)
Table Central & South America Candesartan Cilexetil Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Candesartan Cilexetil Drug Market Share by Product
Table Central & South America Candesartan Cilexetil Drug Sales by End User (2014-2019) (K Units)
Table Central & South America Candesartan Cilexetil Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Candesartan Cilexetil Drug Market Share by End User
Figure Middle East and Africa Candesartan Cilexetil Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Candesartan Cilexetil Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Candesartan Cilexetil Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Candesartan Cilexetil Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Candesartan Cilexetil Drug Sales Market Share by Countries
Table Middle East and Africa Candesartan Cilexetil Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Candesartan Cilexetil Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Candesartan Cilexetil Drug Revenue Market Share by Countries
Figure GCC Countries Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Candesartan Cilexetil Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Candesartan Cilexetil Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Candesartan Cilexetil Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Candesartan Cilexetil Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Candesartan Cilexetil Drug Market Share by Product
Table Middle East and Africa Candesartan Cilexetil Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Candesartan Cilexetil Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Candesartan Cilexetil Drug Market Share by End User
Table AstraZeneca Company Details
Table AstraZeneca Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table ANI Pharmaceuticals Company Details
Table ANI Pharmaceuticals Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ANI Pharmaceuticals Recent Development
Table Mylan Company Details
Table Mylan Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Zydus Pharmaceuticals Company Details
Table Zydus Pharmaceuticals Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zydus Pharmaceuticals Recent Development
Table MACLEODS Company Details
Table MACLEODS Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table MACLEODS Recent Development
Table Alembic Pharmaceuticals Company Details
Table Alembic Pharmaceuticals Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alembic Pharmaceuticals Recent Development
Table Teva Company Details
Table Teva Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Recent Development
Table LUPIN Company Details
Table LUPIN Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table LUPIN Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Recent Development
Table Chongqing Shenghuaxi Pharma Company Details
Table Chongqing Shenghuaxi Pharma Candesartan Cilexetil Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Chongqing Shenghuaxi Pharma Recent Development
Table Global Candesartan Cilexetil Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global Candesartan Cilexetil Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Candesartan Cilexetil Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Candesartan Cilexetil Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Candesartan Cilexetil Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global Candesartan Cilexetil Drug Sales Market Share Forecast by Product 2019-2025
Table Global Candesartan Cilexetil Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Candesartan Cilexetil Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Candesartan Cilexetil Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global Candesartan Cilexetil Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Candesartan Cilexetil Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Candesartan Cilexetil Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Candesartan Cilexetil Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Candesartan Cilexetil Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Candesartan Cilexetil Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Candesartan Cilexetil Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Candesartan Cilexetil Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Candesartan Cilexetil Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Candesartan Cilexetil Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Candesartan Cilexetil Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Candesartan Cilexetil Drug Value Chain
Table Candesartan Cilexetil Drug Customers List
Table Candesartan Cilexetil Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs